Literature DB >> 12671107

Influence of iodine-131 dose on the outcome of hyperthyroidism in children.

Scott A Rivkees1, Eugene A Cornelius.   

Abstract

OBJECTIVES: Iodine-131 is an effective treatment for Graves' hyperthyroidism in children and adults. Yet the responses to treatment as related to iodine-131 dose in children are not well-defined. The objective of this study was to examine the relationship between the dose of iodine-131 in children with hyperthyroidism and thyroid status 1 year after treatment.
METHODS: We examined the outcome of iodine-131 treatment in children and adolescents with Graves' disease, as related to dose. Three iodine-131 doses were compared: 72 to 108 Gy (80-120 microCi/g), 180 to 225 Gy (200-250 microCi/g), and 270 to 364 Gy (300-405 microCi/g) in 31 patients ranging in age from 7 to 18 years old. Thyroid status was assessed >1 year after therapy.
RESULTS: We found that doses of 100 Gy (110 microCi/g), 200 Gy (220 microCi/g), and 300 Gy (330 microCi/g) resulted in hypothyroidism in 50%, 70%, and 95% of treated individuals, respectively. These data show that to insure ablation of thyroid tissue doses, >270 Gy (300 microCi/g) is needed, especially when the thyroid is large.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12671107     DOI: 10.1542/peds.111.4.745

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  17 in total

1.  EANM procedure guidelines for therapy of benign thyroid disease.

Authors:  Marcel P M Stokkel; Daria Handkiewicz Junak; Michael Lassmann; Markus Dietlein; Markus Luster
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-07-13       Impact factor: 9.236

Review 2.  The treatment of Graves' disease in children and adolescents.

Authors:  Hae Sang Lee; Jin Soon Hwang
Journal:  Ann Pediatr Endocrinol Metab       Date:  2014-09-30

Review 3.  Controversies in the management of Graves' disease in children.

Authors:  S A Rivkees
Journal:  J Endocrinol Invest       Date:  2016-05-06       Impact factor: 4.256

4.  Success rate of radioactive iodine treatment for children and adolescent with hyperthyroidism.

Authors:  S Namwongprom; P Dejkhamron; K Unachak
Journal:  J Endocrinol Invest       Date:  2020-06-24       Impact factor: 4.256

5.  The Efficacy and Short- and Long-Term Side Effects of Radioactive Iodine Treatment in Pediatric Graves' Disease: A Systematic Review.

Authors:  Sarah L Lutterman; Nitash Zwaveling-Soonawala; Hein J Verberne; Frederik A Verburg; A S Paul van Trotsenburg; Christiaan F Mooij
Journal:  Eur Thyroid J       Date:  2021-07-12

6.  Myopathy Associated with Acute Hypothyroidism following Radioiodine Therapy for Graves Disease in an Adolescent.

Authors:  Valeria C Benavides; Scott A Rivkees
Journal:  Int J Pediatr Endocrinol       Date:  2010-09-14

7.  Propylthiouracil (PTU) Hepatoxicity in Children and Recommendations for Discontinuation of Use.

Authors:  Scott A Rivkees; Donald R Mattison
Journal:  Int J Pediatr Endocrinol       Date:  2009-04-21

8.  Clinical experience with radioactive iodine in the treatment of childhood and adolescent Graves' disease.

Authors:  Adriano N Cury; Verônica T Meira; Osmar Monte; Marília Marone; Nilza M Scalissi; Cristiane Kochi; Luís E P Calliari; Carlos A Longui
Journal:  Endocr Connect       Date:  2012-12-05       Impact factor: 3.335

9.  Effect of patient Age on surgical outcomes for Graves' disease: a case-control study of 100 consecutive patients at a high volume thyroid surgical center.

Authors:  Christopher K Breuer; Daniel Solomon; Patricia Donovan; Scott A Rivkees; Robert Udelsman
Journal:  Int J Pediatr Endocrinol       Date:  2013-01-25

Review 10.  Hyperthyroidism in childhood: causes, when and how to treat.

Authors:  Juliane Léger; Jean Claude Carel
Journal:  J Clin Res Pediatr Endocrinol       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.